© 2023 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Mektovi

NIH’s ComboMATCH Initiative Will Test New Drug Combinations Guided by Tumor Biology

ComboMATCH comprises numerous clinical trials that will evaluate different drug combinations.

Mektovi

Targeted Drug Trio Improves Survival in Colorectal Cancer With BRAF Mutations

“It’s a great opportunity to help people with colon cancer with this particular mutation. This is a gigantic step in the right direction.â...

3-Drug Therapy Ups Survival in High-Risk Colon Cancer

Braftovi, Mektovi and Erbitux improved outcomes for those with advanced colorectal cancer with BRAF mutation.
Advertisement

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.